z-logo
open-access-imgOpen Access
Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
Author(s) -
Anna Isotta Castrini,
Eystein Skjølsvik,
Mette E Estensen,
Vibeke Marie Almaas,
Helge Skulstad,
Erik Lyseggen,
Thor Edvardsen,
Øyvind Lie,
Kermshlise Picard,
Neal K. Lakdawala,
Kristina H. Haugaa
Publication year - 2022
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.121.024960
Subject(s) - medicine , lmna , cardiology , cardiac resynchronization therapy , pregnancy , interquartile range , implantable cardioverter defibrillator , peripartum cardiomyopathy , ejection fraction , ventricular fibrillation , atrial fibrillation , cardiomyopathy , atrioventricular block , dilated cardiomyopathy , heart failure , sudden cardiac death , lamin , nucleus , psychiatry , biology , genetics
Background We aimed to assess the association between number of pregnancies and long‐term progression of cardiac dysfunction, arrhythmias, and event‐free survival in women with pathogenic or likely pathogenic variants of gene encoding for Lamin A/C proteins ( LMNA+). Methods and Results We retrospectively included consecutive women with LMNA+ and recorded pregnancy data. We collected echocardiographic data, occurrence of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, and implantation of cardiac electronic devices (implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator). We analyzed retrospectively complications during pregnancy and the peripartum period. We included 89 women with LMNA+ (28% probands, age 41±16 years), of which 60 had experienced pregnancy. Follow‐up time was 5 [interquartile range, 3–9] years. We analyzed 452 repeated echocardiographic examinations. Number of pregnancies was not associated with increased long‐term risk of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, or implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator implantation. Women with previous pregnancy and nulliparous women had a similar annual deterioration of left ventricular ejection fraction (−0.5/year versus −0.3/year,P =0.37) and similar increase of left ventricular end‐diastolic diameter (0.1/year versus 0.2/year,P =0.09). Number of pregnancies did not decrease survival free from death, left ventricular assist device, or need for cardiac transplantation. Arrhythmias occurred during 9% of pregnancies. No increase in maternal and fetal complications was observed.Conclusions In our cohort of women with LMNA+, pregnancy did not seem associated with long‐term adverse disease progression or event‐free survival. Likewise, women with LMNA+ generally well‐tolerated pregnancy, with a small proportion of patients experiencing arrhythmias.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom